Werner Lanthaler Reveals Why Wlanholding Avoids Traditional VC Models
Most life sciences investors follow predictable patterns: raise funds from limited partners, deploy capital across portfolio companies within defined timeframes, and exit investments to generate returns for fund investors. Werner Lanthaler has deliberately constructed Wlanholding GmbH to operate outside these conventional frameworks, creating what amounts to an alternative approach to biotechnology investment. The post Werner […]